TGF-β1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells
- 30 September 1996
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 4 (3) , 186-191
- https://doi.org/10.1016/s0966-3274(96)80015-3
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- MULTIPLE VECTORS EFFECTIVELY ACHIEVE GENE TRANSFER IN A MURINE CARDIAC TRANSPLANTATION MODEL IMMUNOSUPPRESSION WITH TGF-β OR vIL-10Transplantation, 1995
- PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL WITH TRANSFORMING GROWTH FACTOR-β1 IN RATSTransplantation, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Donor-derived chimerism in recipients of organ transplantsHepatology, 1993
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992
- Transforming Growth Factor‐β Is a Potent Negative Regulator of Human LymphocytesAnnals of the New York Academy of Sciences, 1991
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Inflammatory and immunomodulatory roles of TGF-βImmunology Today, 1989
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987